Demonstrates improved diagnostic specificity for breast cancer using a novel exosome detection platform, suggesting a new approach for clinical applications.
Tumor-derived exosomes (TEXs), carrying rich proteomic information, have shown great promise as noninvasive biomarkers for cancer detection. However, their inherent heterogeneity, relatively low abundance, and significant interference from non-TEXs in biological fluids pose considerable challenges for accurate and sensitive TEX quantification. To address this, we developed a highly sensitive and specific light-scattering counting platform based on proximity-ligation-mediated rolling circle amplification (RCA), enabling single-particle detection of exosomes. The approach employs dual aptamers that bind specifically to a single exosome, triggering proximity ligation and RCA. This process promotes the aggregation of small gold nanoparticles (AuNPs), generating a strong turn-on light-scattering signal from an initial near-zero background, which is then visualized as diffraction-limited spots. By using a single microbead as the signal enrichment platform to concentrate all exosome-derived signals, we achieved a detection sensitivity as low as 1 particle/μL. Furthermore, conjoint analysis of pairwise combinations of multiple exosomal proteins significantly improved diagnostic specificity, allowing precise discrimination between breast cancer patients and healthy individuals using just 1 μL of clinical plasma. By targeting other cancer-specific biomarkers, this platform can be readily adapted to detect other cancers, offering a versatile and scalable tool for early cancer diagnosis in the field of liquid biopsy.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: